CTIS2023-506267-33-00招募中1 期
A Phase 1b Study of JNJ-90014496 in Adult Participants with Relapsed or Refractory B-cellNon-Hodgkin Lymphoma
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
An Open-label, Multicenter, Phase 1b Study of JNJ-63723283, a PD-1 Inhibitor, Administered in Combination with Apalutamide in Subjects with Metastatic Castration- Resistant Prostate CancerNL-OMON50489Janssen-Cilag8
已完成
1 期
A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT03235219Janssen Research & Development, LLC39
进行中（未招募）
不适用
A Study of JNJ-40346527 in Patients with Relapsed or Refractory Hodgkin LymphomaSubjects with Relapsed or Refractory Hodgkin’s LymphomaMedDRA version: 15.1Level: LLTClassification code 10020328Term: Hodgkin's lymphomaSystem Organ Class: 100000004864EUCTR2011-005795-42-DEJanssen Cilag International N.V.68
进行中（未招募）
1 期
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell non-Hodgkin Lymphoma (r/r B-NHL)on-Hodgkin Lymphoid MalignanciesCancerISRCTN17666983Janssen-Cilag International NV92
已完成
2 期
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary DiseaseNCT01867762Janssen Research & Development, LLC211